Primary Recommendation

Tungsten - Demand for e-invoicing at record high

May 2014

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

It is very unusual for SCSW to write a profile on a company that is still lossmaking but I am increasingly coming to believe that Tungsten could prove to be one of the really great investments in coming months. Tungsten operates OB10, one of the largest business-to-business e-invoicing platforms, which enables suppliers to upload their invoices electronically as an alternative to sending out paper-based ones. The attractive thing is that OB10 is hard wired into the accounts departments of some of the worlds largest organisations, including Apple, Unilever, Glaxo, Barclays and Tesco. It also has 63% of the Fortune500 as customers. It's an incredible position to be in because each of these buyers creates a captive group of supplier ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Market Comment - May '14

Energy Assets - Deregulation in the gas meter market

Tungsten (December 2016)

Tungsten - Shares double since January (March 2016)

Tungsten - 70% uplift on H1 software renewal pricing (January 2016)

Tungsten (June 2015)

Tungsten (April 2015)

Tungsten (March 2015)

Tungsten (February 2015)

Tungsten - Enters into "multi billion dollar" financing (January 2015)

Tungsten - Trading ahead of expectations in first four months (October 2014)

Tungsten (September 2014)

Tungsten - GE to roll-out Tungsten into each location (June 2014)

Tungsten (April 2014)

Tungsten - Appoints reseller in Mexico (March 2014)

Tungsten (February 2014)

Tungsten (December 2013)

Tungsten - E-invoicing business couldwin B-I-G (November 2013)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X